GSE201409 coumarin Hep-G2 1 v 6 human up (Gene Set)

Analyze

Playbook Workflow Builder
Playbook Workflow Builder: Gene Set Enrichment

Perform Gene Set Enrichment with this gene set against Common Fund program's gene sets, identifying significant overlaps using a pre-built PWB workflow. Run the workflow with GSE201409_coumarin_Hep-G2_1_v_6_human_up.

GeneSetCart
GeneSetCart

GeneSetCart helps you to fetch gene sets from various data sources, augment, combine with set operations, visualize and analyze these gene sets in a single session. Start a new session with GSE201409_coumarin_Hep-G2_1_v_6_human_up.

CFDE-GSE
CFDE Gene Set Enrichment (GSE)

CFDE-GSE illuminates connections between the input gene set and various CF gene sets that overlap with the queried gene set. Query CFDE-GSE with GSE201409_coumarin_Hep-G2_1_v_6_human_up.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with GSE201409_coumarin_Hep-G2_1_v_6_human_up.

Results found

Linked to

 

Label

Description

 

Gene

CTDP1 divergent transcript

Gene

uncharacterized LOC100505782

Gene

RNA, 7SL, cytoplasmic 650, pseudogene

Gene

ribosomal protein L36a pseudogene 26

Gene

microRNA 661

Gene

long intergenic non-protein coding RNA 2079

Gene

long intergenic non-protein coding RNA 1643

Gene

small nucleolar RNA U109

Gene

ribosomal protein L23a pseudogene 94

Gene

RNA, U6 small nuclear 1267, pseudogene

  • Gene

    CTDP1 divergent transcript


  • Gene

    uncharacterized LOC100505782


  • Gene

    RNA, 7SL, cytoplasmic 650, pseudogene


  • Gene

    ribosomal protein L36a pseudogene 26



  • Gene

    long intergenic non-protein coding RNA 2079


  • Gene

    long intergenic non-protein coding RNA 1643


  • Gene

    small nucleolar RNA U109


  • Gene

    ribosomal protein L23a pseudogene 94


  • Gene

    RNA, U6 small nuclear 1267, pseudogene

  • DISPLAY PER PAGE
    This repository is under review for potential modification in compliance with Administration directives.